Filing Details
- Accession Number:
- 0001209191-20-001770
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-01-06 16:17:44
- Reporting Period:
- 2020-01-02
- Accepted Time:
- 2020-01-06 16:17:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1446372 | M Paul Silva | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Svp & Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-01-02 | 16,758 | $109.14 | 34,517 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-02 | 3,867 | $91.05 | 38,384 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-02 | 2,578 | $90.29 | 40,962 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-01-02 | 2,427 | $86.52 | 43,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-01-02 | 2,842 | $217.68 | 40,547 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-02 | 10,040 | $218.70 | 30,507 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-02 | 12,648 | $219.37 | 17,859 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-01-02 | 100 | $220.07 | 17,759 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy) | Disposition | 2020-01-02 | 16,758 | $0.00 | 16,758 | $109.14 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2020-01-02 | 3,867 | $0.00 | 3,867 | $91.05 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2020-01-02 | 2,578 | $0.00 | 2,578 | $90.29 |
| Common Stock | Stock Option (Right to buy) | Disposition | 2020-01-02 | 2,427 | $0.00 | 2,427 | $86.52 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2025-02-02 | No | 4 | M | Direct | |
| 1,290 | 2026-02-01 | No | 4 | M | Direct | |
| 2,579 | 2026-07-11 | No | 4 | M | Direct | |
| 4,045 | 2027-02-02 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 169 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $217.68 (range $217.08 to $218.02).
- Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $218.70 (range $218.07 to $219.06).
- Open market sales reported on this line occurred at a weighted average price of $219.37 (range $219.07 to $219.82).
- Fully vested.
- The option vests in 16 quarterly installments from 02/02/2016.
- The option vests in 16 quarterly installments from 07/12/2016.
- The option vests in 16 quarterly installments from 02/03/2017.
Billionaire Hedge Funds
